Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
03/22/2011 | CA2455939C Sucralose formulations to mask unpleasant tastes |
03/22/2011 | CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof |
03/22/2011 | CA2433675C Pharmaceutically active piperidine derivatives |
03/22/2011 | CA2412050C A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
03/22/2011 | CA2397294C Glyburide composition |
03/22/2011 | CA2396186C Agents for the treatment of skin disorders |
03/22/2011 | CA2382636C Fish feed with increased nucleotide content |
03/22/2011 | CA2344690C Fructosamine oxidase: antagonists and inhibitors |
03/22/2011 | CA2335941C Treatment of hyperproliferative disorders |
03/22/2011 | CA2308127C Agonist and antagonist peptides of carcinoembryonic antigen (cea) |
03/22/2011 | CA2136958C Method for inhibition of viral morphogenesis |
03/17/2011 | WO2011032179A1 Vaccines and immunotherapeutics comprising il-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same |
03/17/2011 | WO2011030859A1 Skin-whitening composition |
03/17/2011 | WO2011030847A1 Inducer composition for hematopoietic stem cells |
03/17/2011 | WO2011029170A1 Process to obtain a homeopathic medicament and use thereof |
03/17/2011 | WO2011002953A3 Topical skin treatment kits |
03/17/2011 | WO2010093789A8 A composition comprising (-) -trans-3- (5, 6-dihydro-4h-pyrrolo [3,2,1-ij] quinolin-1-yl)-4-(1h-indol-3-yl) pyrrolidine- 2, 5-dione in combination with a second anti-proliferative agent |
03/17/2011 | US20110066251 Anti-angiogenic compositions and methods of use |
03/17/2011 | US20110065773 Rna interference mediating small rna molecules |
03/17/2011 | US20110065763 Compositions for Topical Application Having Androgenic Actions |
03/17/2011 | US20110065729 Methods and compositions for ameliorating the undesirable effects of chemotherapy |
03/17/2011 | US20110065147 Methods and reagents for modulating cholesterol levels |
03/17/2011 | US20110065109 Rna interference mediating small rna molecules |
03/17/2011 | US20110064791 Self forming, thermodynamically stable liposomes and their applications |
03/17/2011 | US20110064734 Prevention and treatment of amyloidogenic disease |
03/17/2011 | US20110064729 Administration of agents for the treatment of inflammation |
03/17/2011 | US20110064718 Pesticidal and Antiparasitic Compositions |
03/17/2011 | US20110061651 Formoterol superfine formulation |
03/16/2011 | EP2295604A2 Diagnosis and treatment of cancers with microRNA located in or near cancer-associated chromosomal features |
03/16/2011 | EP2295467A1 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
03/16/2011 | EP2295454A1 SLO2, a novel potassium channel protein from human brain |
03/16/2011 | EP2295444A2 Lipopeptides as antibacterial agents |
03/16/2011 | EP2295413A1 Indazole compounds useful as protein kinase inhibitors |
03/16/2011 | EP2295412A1 Indazole compounds useful as protein kinase inhibitors |
03/16/2011 | EP2295409A1 Fluoro substituted cycloalkanoindoles and their use as prostaglandin D2 receptor antagonists |
03/16/2011 | EP2295083A1 Pharmaceutical composition comprising active agents metformin and sitagliptin or vildagliptin |
03/16/2011 | EP2295081A1 Antibodies to OPGL |
03/16/2011 | EP2295079A2 Method for treating inflammation |
03/16/2011 | EP2295078A2 Method for treating inflammation |
03/16/2011 | EP2295065A1 Modified heat shock protein-antigenic peptide complex |
03/16/2011 | EP2295062A1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
03/16/2011 | EP2295060A2 Stabilization of hypoxia inducible factor (HIF) alpha |
03/16/2011 | EP2295059A2 Stabilization of hypoxia inducible factor (HIF) alpha |
03/16/2011 | EP2295057A1 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
03/16/2011 | EP2295055A2 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof |
03/16/2011 | EP2295052A1 Use of ritonavir for improving the pharmacokinetics of drugs metabolized by cytochrome P450 |
03/16/2011 | EP2295049A1 Treatment of autoimmune diseases |
03/16/2011 | EP2295048A1 Synergistic anti-inflammatory pharmaceutical compositions comprising IAA and RIAA |
03/16/2011 | EP2295047A2 Use of adenosine A2a receptor antagonists for the treatment of restless leg syndrome and other movement disorders |
03/16/2011 | EP2295028A1 Preparation for preventing or ameliorating wrinkles, to be taken orally, through injection, or through external application to skin, and cosmetic method |
03/16/2011 | EP2294428A1 A polymer adapted to release bioactive agents in vivo, pharmaceutical composition and method of preparation thereof |
03/16/2011 | EP2294210A2 Efficient wellbeing assessment and improved treatment protocol |
03/16/2011 | EP2294012A1 Methods of treating bowel disease by administering a bowel cleanser and an antibiotic |
03/16/2011 | EP2293802A2 Lactose compositions with decreased lactose content |
03/16/2011 | EP2293790A2 Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders |
03/16/2011 | EP2293778A2 Composition comprising an antibiotic and a corticosteroid |
03/16/2011 | EP2293777A1 Pharmaceutical transdermal compositions and method for treating inflammation in cattle |
03/16/2011 | EP2083796B1 Metal coated nanoparticles for use in the treatment of enzymatic dermatitis |
03/16/2011 | EP1841459B1 Use of a dihydroim1dazopyrazine derivative for treating or preventing pain |
03/16/2011 | EP1631266B1 A method of treating degenerative disc disease |
03/16/2011 | EP1513507B1 Transdermal analgesic systems with reduced abuse potential |
03/16/2011 | EP1412388B1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
03/16/2011 | CN101985044A Taste-masking medicinal coating composition |
03/16/2011 | CN101985042A Medicinal composition for resisting thrombus |
03/16/2011 | CN101985041A Clopidogrel- and stanin compounds-containing medicinal composition |
03/16/2011 | CN101985040A Novel medicinal composition |
03/16/2011 | CN101985039A Medicinal composition for resisting thrombus |
03/16/2011 | CN101985038A Medicinal composition for resisting thrombus |
03/16/2011 | CN101985037A Applications of receptor for activated C-kinase 1 as target against tumor drug-resistance |
03/16/2011 | CN101081212B Protease inhibitors liposomes aerosol |
03/15/2011 | US7906616 Truncated DANCE, DANCE complex and method of using these |
03/15/2011 | US7906554 Combination chemotherapy compositions and methods |
03/15/2011 | US7906497 Cancer treatment methods |
03/15/2011 | US7906483 Method for treating transplant rejection |
03/15/2011 | US7906128 Controlling parasites in animals by administerinng sodium channel activators |
03/15/2011 | US7906125 a biodisintegrable binder (e.g., a biodisintegrable polymer or organic compound) and a chemical ablation agent (e.g., a salt), effective to cause tissue necrosis; injectable or insertable dosage forms; chemoablation of tissue, such as prostate |
03/15/2011 | US7906112 Canine probiotic Lactobacilli |
03/15/2011 | CA2677910C The use of inhibitors of the renin-angiotensin system for the treatment of cardiovascular diseases |
03/15/2011 | CA2613030C Agent for the treatment of herpes virus-derived pain |
03/15/2011 | CA2562982C Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
03/15/2011 | CA2496780C Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same |
03/15/2011 | CA2480708C Method and dietary composition for improving fat digestibility |
03/15/2011 | CA2470703C Oral pharmaceutical products containing 17.beta.-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
03/15/2011 | CA2470583C Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes |
03/15/2011 | CA2434169C Spaced drug delivery system |
03/15/2011 | CA2433806C Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
03/15/2011 | CA2431160C Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
03/15/2011 | CA2406008C Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
03/15/2011 | CA2389302C Delivery of proteins across polar epithelial cell layers |
03/15/2011 | CA2376158C Use of selective estrogen receptor modulators in the manufacture of medicaments for treating and/or suppressing weight gain |
03/15/2011 | CA2373653C New use of compounds as antibacterial agents |
03/10/2011 | WO2011028814A1 Methods of engineering neural tissue |
03/10/2011 | WO2011028621A1 Method of treating compulsive disorders with alpha-2b adrenergic receptor agonists |
03/10/2011 | WO2011027807A1 Immunity inducer |
03/10/2011 | WO2011027344A2 Combination of vitamin e and beta-glycosphingolipids in compositions and methods for preventing and treating hepatic disorders |
03/10/2011 | WO2011027119A1 Combination medicament |
03/10/2011 | WO2011009020A3 Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers |
03/10/2011 | WO2010130462A8 Phosphate-free pharmaceutical composition for the treatment of glaucoma |
03/10/2011 | US20110060016 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
03/10/2011 | US20110060014 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |